humanitarian
Human medicines European public assessment report (EPAR): Spevigo, spesolimab, Date of authorisation: 09/12/2022, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Phesgo, pertuzumab,trastuzumab, Date of authorisation: 21/12/2020, Revision: 8, Status: Authorised
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
12 reports · 2 sources
EMA What Is NewHuman medicines European public assessment report (EPAR): Spevigo, spesolimab, Date of authorisation: 09/12/2022, Revision: 6, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Spevigo, spesolimab, Date of authorisation: 09/12/2022, Revision: 6, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): KemSu, sufentanil,ketamine, Status: RefusedEMA What Is NewHuman medicines European public assessment report (EPAR): Meplyffa, arimoclomol, Status: RefusedEMA What Is NewHuman medicines European public assessment report (EPAR): Ruxolitinib Krka, ruxolitinib, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Donrafylix, insulin aspart, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Zybrivo, sintilimab, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Fondaparinux sodium Evumed, fondaparinux sodium, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Amlypave, anselamimab, Status: Application withdrawnEMA What Is NewHuman medicines European public assessment report (EPAR): Baxfendy, baxdrostat, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): Garzulys, insulin aspart, Status: OpinionEMA What Is NewHuman medicines European public assessment report (EPAR): KemSu, sufentanil,ketamine, Status: Refused4 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources